LSX World Congress

STRATEGY, INVESTMENT, PARTNERING & COMMERCIALISATION FOR LIFE SCIENCE EXECUTIVE LEADERS

 

8th Annual



8-9 February 2022
133 Houndsditch, Liverpool St
London, UK


DOWNLOAD BROCHURE

FOR BIOTECH
FOR HEALTHTECH
FOR MEDTECH

LSX World Congress Virtual


For 7 years, the LSX World Congress has been bringing together the executives that matter to the future of healthcare and life science strategy, investment, partnering and deal making. 

LSX World Congress gathers the founders and CEOs of innovative start-ups through to publicly listed life sciences giants, and everyone in between. It represents the breadth and depth of the cutting-edge research and technology driving the advances in the industry right now and in the near future.

The industry’s c-suite will be joined by the sector’s most active investors, pharma and health tech BD&L teams, R&D leaders, KOLs and top tier service companies who are moving the sector forward.

In an industry as dynamic as the life science and healthcare sector, LSX World Congress brings the people who are tackling the biggest challenges in the industry today, and helps answer the question; where to next and how do we get there?

With our relentless focus on quality peer-to-peer discussion, high-level networking and partnering, intimate conference formats and a vetted, high-calibre audience, we help you Connect with Purpose.

The event continues to focus on Biotech Leaders, Medtech Leaders and Healthtech Leaders. We hope you can join us. 

LSX World Congress

DOWNLOAD BROCHURE

The premier event for leaders in life sciences investment, partnering, technology, business and strategy

2021 Key Speakers


Alex Aravanis, Chief Technology Officer, Illumina

Alex Aravanis

Chief Technology Officer
Illumina
Thomas Breuer, SVP and Chief Medical Officer, GSK Vaccines

Thomas Breuer

SVP and Chief Medical Officer
GSK Vaccines
Adrian Cassidy, Global Head of Real-World Evidence, Novartis

Adrian Cassidy

Global Head of Real-World Evidence
Novartis
Maria Dahl, COO and Head of Europe, Innovent Bio

Maria Dahl

COO and Head of Europe
Innovent Bio
Didier Deltort, President, Europe, Middle East and Africa, Zimmer Biomet

Didier Deltort

President, Europe, Middle East and Africa
Zimmer Biomet
Jennifer Esposito, VP Health, Magic Leap

Jennifer Esposito

VP Health
Magic Leap
Jessica Federer, Venture Partner, Boston Millennia Partners

Jessica Federer

Partner
Boston Millennia Partners
Doug Giordano, SVP Worldwide BD, Pfizer

Doug Giordano

SVP Worldwide BD
Pfizer
Lara Koole, Partner, Philips Ventures, Philips

Lara Koole

Partner, Philips Ventures
Philips
Adam Landman, Chief Information Officer, Digital Innovation Officer, Brigham Health

Adam Landman

Chief Information Officer, Digital Innovation Officer
Brigham Health
Sean Marett, CBO, BioNTech

Sean Marett

CBO
BioNTech
Elizabeth Mily, EVP BD, Bristol Myers Squibb

Elizabeth Mily

EVP BD
Bristol Myers Squibb
Aradhana Sarin, CFO, Alexion Pharmaceuticals

Aradhana Sarin

CFO
Alexion Pharmaceuticals
Jeffrey Shuren, Director, CDRH, FDA

Jeffrey Shuren

Director, CDRH
FDA
Ben Thorner, SVP and Head MRL Business Development & Licensing, Merck & Co

Ben Thorner

SVP & Head MRL Business Development & Licensing
Merck & Co
Glenn Tullman, CEO, Livongo

Glenn Tullman

CEO
Livongo

SEE ALL SPEAKERS

2021 Key Event Stats


3000+

REGISTERED PARTICIPANTS

700+

INVESTORS, STRATEGICS & PHARMA

1750+

UNIQUE ORGANISATIONS

1500+

BIOTECH, MEDTECH, HEALTHTECH

& DEEPTECH COMPANIES

160+

COMPANY

SHOWCASES

40+

COUNTRIES REPRESENTED FROM

7 CONTINENTS

Platinum Partners


ZS

Gold Partners


Beigene
Bird & Bird 300x150

Cello BioConsulting
Cello Health Consulting 300x150
citi 300x150

Goodwin 300x150

Potter Clarkson
Latham & Watkins 300x
Medtronic 300x150
MSD Inventing For Life
Innovate UK
Premier Research 300x150
SVB Leerink 300x150

Knowledge Partner


McKinsey

Silver Partners


Greenlight Guru
Halloran 300x
Huron 300x

Lonza Pharma & Biotech

MAVIE Technologies

DOWNLOAD BROCHURE